Cited by 164Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchNeuroscience of respiration and sleep

Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5‐hydroxtryptamine system

Open access
Haddjeri, Nasser, De Montigny, Claude, Blier, Pierre·1997·British Journal of Pharmacology

Abstract

The aim of the present study was to investigate the putative modulation of locus coeruleus (LC) noradrenergic (NA) neurones by the 5‐hydroxytryptaminergic (5‐HT) system by use of in vivo extracellular unitary recordings and microiontophoresis in anaesthetized rats. To this end, the potent and selective 5‐HT 1A receptor antagonist WAY 100635 (N‐{2‐[4(2‐methoxyphenyl)‐1‐piperazinyl]ethyl}‐N‐(2‐pyridinyl)cyclohexanecarboxamide trihydroxychloride) was used. In the dorsal hippocampus, both local (by microiontophoresis, 20 nA) and systemic (100 μg kg−1, i.v.) administration of WAY 100635 antagonized the suppressant effect of microiontophorectically‐applied 5‐HT on the firing activity of CA 3 pyramidal neurones, indicating its antagonistic effect on postsynaptic 5‐HT 1A receptors. WAY 100635 and 5‐HT failed to modify the spontaneous firing activity of LC NA neurones when applied by microiontophoresis. However, the intravenous injection of WAY 100635 (100 μg kg−1) readily suppressed the spontaneous firing activity of LC NA neurones. The lesion of 5‐HT neurones with the neurotoxin 5,7‐dihydroxytryptamine increased the spontaneous firing activity of LC NA neurones and abolished the suppressant effect of WAY 100635 on the firing activity of LC NA neurones. In order to determine the nature of the 5‐HT receptor subtypes mediating the suppressant effect of WAY 100635 on NA neurone firing activity, several 5‐HT receptor antagonists were used. The selective 5‐HT 3 receptor antagonist BRL 46470A (10 and 100 μg kg−1, i.v.), the 5‐HT 1D receptor antagonist GR 127935 (100 μg kg−1, i.v.) and the 5‐HT 1A/1B receptor antagonist (−)‐pindolol (15 mg kg−1, i.p.) did not prevent the suppressant effect of WAY 100635 on the firing activity of LC NA neurones. However, the suppressant effect of WAY 100635 was prevented by the non‐selective 5‐HT receptor antagonists spiperone (1 mg kg−1, i.v.) and metergoline (1 mg kg−1, i.v.), by the 5‐HT 2 receptor antagonist ritanserin (500 μg kg−1, i.v.). It was also prevented by the 5‐HT 1A receptor/α 1D‐adrenoceptor antagonist BMY 7378 (1 mg kg−1, i.v.) and by the α 1‐adrenoceptor antagonist prazosin (100 μg kg−1, i.v.). These data support the notion that the 5‐HT system tonically modulates NA neurotransmission since the lesion of 5‐HT neurones enhanced the LC NA neurones firing activity and the suppressant effect of WAY 100635 on the firing activity of NA neurones was abolished by this lesion. However, the location of the 5‐HT 1A receptors involved in this complex circuitry remains to be elucidated. It is concluded that the suppressant effect of WAY 100635 on the firing activity of LC NA neurones is due to an enhancement of the function of 5‐HT neurones via a presynaptic 5‐HT 1A receptor. In contrast, the postsynaptic 5‐HT receptor mediating this effect of WAY 100635 on NA neurones appears to be of the 5‐HT 2A subtype. British Journal of Pharmacology (1997) 120, 865–875; doi:10.1038/sj.bjp.0700968

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0700968

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Long-term use of SSRIs can increase 5-HT transmission in the LC, thereby increasing the release of GABA to exert inhibitory effects on NA neurons.

    “Third, long-term use of SSRIs can increase 5-HT transmission in the LC, 362 thereby increasing the release of GABA to exert inhibitory effects on NA neurons. 363”

    From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [362]

    The Discussion (page unavailable) reports tonic inhibition of rat LC noradrenergic neurons by the 5-HT system. The Introduction (page unavailable) describes increased GABA inhibitory input as a proposed explanation for the effect of a 5-HT2 agonist. Neither passage establishes that long-term SSRI use increases 5-HT transmission in the LC or GABA release. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Youdim, M.B.H., Lovenberg, W., Sharman, D.F., Lagnado, J.R. pp. 2 ± 32. New York: J. Wiley & Sons.
  2. Isaacson, R.L. & Pribram, K.H. pp. 207 ± 244. New York: Plenum.

Cited by

Sorted by citations

Authors
Haddjeri, N., De Montigny, C., & Blier, P.
Affiliations
McGill University (CA)
Corresponding author
Haddjeri, Nasser
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1997-02
Volume
120
Issue
5
Pages
865-875
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1965641144
Cited by
164
References
76
Citations by year
2026: 4 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 7 · 2016: 2 · 2015: 3 · 2014: 10 · 2013: 4 · 2012: 7
FWCI
3.94
Type
journal article
Language
en
Open access
Locations
  • British Journal of Pharmacology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Medical Research Council Canada
  • Medical Research Council
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
Keywords
locus coeruleus, noradrenergic neurons, serotonin, WAY-100635, 5-HT1A receptor, neuronal firing, CA3 pyramidal cells, dorsal hippocampus, 5,7-dihydroxytryptamine lesion, 5-HT receptor subtypes
MeSH terms
Animals, Hippocampus, Iontophoresis, Locus Coeruleus, Male, Neurons, Norepinephrine, Piperazines, Pyridines, Serotonin, Serotonin Antagonists, Rats, Sprague-Dawley, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review